GILEAD SCIENCES, INC. - Common Stock (GILD)

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock
Shares outstanding
1,240,722,841
Total 13F shares
983,518,897
Share change
-13,831,124
Total reported value
$58,461,421,407
Put/Call ratio
95%
Price per share
$59.45
Number of holders
1,543
Value change
-$867,133,541
Number of buys
791
Number of sells
745

Institutional Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q1 2022

As of 31 Mar 2022, GILEAD SCIENCES, INC. - Common Stock (GILD) was held by 1,543 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 983,518,897 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Capital Research Global Investors, Capital World Investors, Dodge & Cox, GEODE CAPITAL MANAGEMENT, LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, RENAISSANCE TECHNOLOGIES LLC, and NORTHERN TRUST CORP. This page lists 1,558 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.